Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.45B |
| 2 |
Visa
V
|
+$1.05B |
| 3 |
Microsoft
MSFT
|
+$1.01B |
| 4 |
Apple
AAPL
|
+$578M |
| 5 |
Norfolk Southern
NSC
|
+$545M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HES
Hess
HES
|
+$1.24B |
| 2 |
McDonald's
MCD
|
+$707M |
| 3 |
JPMorgan Chase
JPM
|
+$680M |
| 4 |
Texas Instruments
TXN
|
+$678M |
| 5 |
Edwards Lifesciences
EW
|
+$664M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.8% |
| 2 | Healthcare | 2.66% |
| 3 | Financials | 2.38% |
| 4 | Consumer Discretionary | 2.05% |
| 5 | Industrials | 2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SUIG
12226
CALL
Sui Group Holdings
SUIG
$70.4M
| $42.8K | ﹤0.01% |
+11,100
| New | +$50.1K |
|
12227
CALL
Destination XL Group
DXLG
$31.4M
| $42.6K | ﹤0.01% |
32,500
-118,900
| -79% | -$156K |
|
12228
Battalion Oil
BATL
$29.7M
| $42.6K | ﹤0.01% |
35,173
+10,189
| +41% | +$12.5K |
|
|
FARM
12229
DELISTED
Farmer Brothers
FARM
| $42.5K | ﹤0.01% |
24,864
-82,867
| -77% | -$144K |
|
12230
CALL
Fate Therapeutics
FATE
$300M
| $42.3K | ﹤0.01% |
33,600
-27,500
| -45% | -$29.7K |
|
|
ALMS
12231
CALL
Alumis Inc
ALMS
$3.46B
| $42.3K | ﹤0.01% |
10,600
-96,000
| -90% | -$395K |
|
12232
PUT
Immunic
IMUX
$191M
| $42.2K | ﹤0.01% |
4,790
+3,010
| +169% | +$26.5K |
|
12233
CALL
OmniAb
OABI
$290M
| $41.9K | ﹤0.01% |
+26,200
| New | +$47.9K |
|
|
LHSW
12234
Lianhe Sowell International Group
LHSW
$8.35M
| $41.9K | ﹤0.01% |
+1,264
| New | +$48.1K |
|
|
SLAI
12235
PUT
DELISTED
SOLAI Ltd ADS
SLAI
| $41.9K | ﹤0.01% |
2,214
+757
| +52% | +$15.8K |
|
|
MGF
12236
Aberdeen Government Markets Income Fund
MGF
$92.2M
| $41.7K | ﹤0.01% |
13,361
-12,166
| -48% | -$37.6K |
|
12237
CALL
Playtika
PLTK
$1.54B
| $41.6K | ﹤0.01% |
10,700
-6,200
| -37% | -$25.3K |
|
12238
PUT
Jasper Therapeutics
JSPR
$22.1M
| $41.4K | ﹤0.01% |
17,400
-100
| -0.6% | -$303 |
|
12239
Martin Midstream Partners
MMLP
$95.5M
| $41.3K | ﹤0.01% |
+13,490
| New | +$42.2K |
|
12240
Ispire Technology
ISPR
$90.7M
| $41.3K | ﹤0.01% |
+16,116
| New | +$46.8K |
|
|
AUTL
12241
PUT
Autolus Therapeutics
AUTL
$519M
| $41.2K | ﹤0.01% |
25,300
-3,400
| -12% | -$6.64K |
|
12242
Mediaco Holding
MDIA
$80.7M
| $41.1K | ﹤0.01% |
+32,354
| New | +$42.3K |
|
|
TRIB
12243
Trinity Biotech
TRIB
$7.43M
| $41K | ﹤0.01% |
+1,313
| New | +$41.4K |
|
|
GNTA
12244
Genenta Science
GNTA
$61.2M
| $41K | ﹤0.01% |
+12,486
| New | +$44.2K |
|
12245
Magic Empire Global Ltd
MEGL
$6.08M
| $40.9K | ﹤0.01% |
+26,900
| New | +$40.2K |
|
|
GITS
12246
Global Interactive Technologies
GITS
$7.75M
| $40.8K | ﹤0.01% |
+17,900
| New | +$43.6K |
|
|
ZBAO
12247
Zhibao Technology Inc
ZBAO
$8.69M
| $40.8K | ﹤0.01% |
40,774
-21,922
| -35% | -$22.3K |
|
12248
Lipocine
LPCN
$17.6M
| $40.7K | ﹤0.01% |
+14,247
| New | +$43.3K |
|
12249
Bridgeline Digital
BLIN
$14.9M
| $40.7K | ﹤0.01% |
+31,069
| New | +$43.8K |
|
|
ROLR
12250
High Roller Technologies
ROLR
$68.3M
| $40.5K | ﹤0.01% |
+14,472
| New | +$39.9K |
|
Similar funds
Citadel Advisors's Q3 2025 Portfolio in Review
As of Q3 2025, Citadel Advisors held 14,587 positions worth $657B, up 14% from $576B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Citadel Advisors's Q3 2025 filing shows 2,292 new, 5,365 increased, 4,887 reduced and 1,963 closed positions. Its largest new stake was Permian Resources: 18,381,735 shares worth $235M. The largest sale was Hess, an estimated $1.24B.
By sector, the portfolio is most concentrated in Technology at 3.8% of assets, up from 3.3% a quarter earlier, followed by Healthcare and Financials.
- Citadel Advisors's largest Q3 2025 buy was Permian Resources: 18,381,735 shares worth $235M.
- Citadel Advisors added most to Meta Platforms (Facebook) in Q3 2025, an estimated $1.45B increase.
- Citadel Advisors's biggest Q3 2025 reduction was McDonald's, cutting an estimated $707M.
- Citadel Advisors fully exited Hess in Q3 2025, selling an estimated $1.24B.
- Citadel Advisors's ten largest holdings make up 25% of its $657B portfolio in Q3 2025.
- Citadel Advisors opened 2,292 new positions and closed 1,963 in Q3 2025.
- Citadel Advisors's portfolio value rose 14% quarter-over-quarter to $657B.
Based on Citadel Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.